Tuberculosis News and Research

Latest Tuberculosis News and Research

Watching transformation of the Global Fund on its 10th anniversary

"Are we watching the rebirth of the troubled Global Fund to Fight Aids, Tuberculosis and Malaria, perhaps in a new, more U.S.-flavored guise?" Guardian health editor Sarah Boseley asks in her "Global Health Blog."

27 Jan 2012

Responding to emergence of drug-resistant tuberculosis

This post in the Center for Strategic and International Studies' "Smart Global Health" blog examines drug-resistant tuberculosis (TB), stating, "[S]ince the recent outbreak of the so-called totally drug-resistant tuberculosis (TDR-TB) in India, TB has a new face."

27 Jan 2012

Reflecting on Global Fund's decade of accomplishment, looking forward to challenges ahead

"This week marks the 10th anniversary of the creation of the Global Fund to Fight AIDS, Tuberculosis and Malaria -- the world's most powerful tool for improving health -- at the World Economic Forum (WEF) in Davos, Switzerland," Natasha Bilimoria, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, writes in this post in the AlertNet "Insight" blog.

27 Jan 2012

Gates pledges $750 million to Global Fund

Speaking at the World Economic Forum in Davos, Switzerland, on Thursday, Bill Gates, co-chair of the Bill & Melinda Gates Foundation, pledged $750 million on behalf of the foundation to the Geneva-based Global Fund to Fight AIDS, Tuberculosis and Malaria, the Associated Press reports.

27 Jan 2012

Gates urges governments, wealthy donors not to cut aid to poor countries; Annual letter sets foundation's priorities

In a speech to the European Parliament on Tuesday, Bill Gates, co-chair of the Bill & Melinda Gates Foundation, "told European lawmakers in Brussels not to cut aid to poor countries despite the economic and budgetary problems facing" European Union (E.U.) countries, Agence France-Presse reports.

27 Jan 2012

First Edition: January 26, 2012

Today's health policy headlines include reports about House GOP plans to offer a 'replace' bill after the Supreme Court rules on the health law.

26 Jan 2012

Latest attacks in Jonglei, South Sudan, perpetuate a pattern of extreme violence, says Médecins Sans Frontières

In the state of Jonglei in South Sudan, civilians continue to bear the brunt of inter-communal fighting. Wounded patients are still arriving at the Médecins Sans Frontières hospital in Pibor, three weeks after the violent attack on the town and outlying villages in Pibor County. Many were injured in the bush, where thousands have remained, afraid to come out of hiding. Médecins Sans Frontières medical teams are now treating serious wound infections, some several weeks old. Since re-launching emergency medical activities in Pibor on 7 January, Médecins Sans Frontières has treated 47 patients with gunshot wounds – 16 women and 8 children. A further 43 patients have so far been treated for stab wounds, beatings or wounds sustained while fleeing in the bush.

24 Jan 2012

Address drug resistant pathogens as part of 'next stage of global health'

This post in the Foreign Policy Association blog discusses reports from earlier this month of "an emerging strain of 'totally drug-resistant' tuberculosis (TDR-TB)" in India, which the Indian government last week denied, "arguing that the 12 cases were in fact extensively drug resistant (XDR)."

24 Jan 2012

U.S. should assume leadership role in saving Global Fund

A funding shortfall led the Global Fund to Fight AIDS, Tuberculosis and Malaria to announce in November that "it won't make any grants to fund programs for at least two years," a Deseret News editorial notes and calls on the U.S. to take a leadership position in saving the fund.

24 Jan 2012

International HIV/AIDS Alliance releases report examining potential effects of Global Fund shortfall

The non-governmental organization (NGO) International HIV/AIDS Alliance has released a new report in response to the Global Fund to Fight AIDS, Tuberculosis and Malaria's announcement in November that "no new grants would be approved until 2014," VOA News reports.

24 Jan 2012

Cooperation needed to fight TB

In this post in Global Health Frontline News' "Notes From the Field" blog, Kevin Cain, chief of the tuberculosis (TB) branch for a research and public health collaboration between the Kenya Medical Research Institute (KEMRI) and the CDC in Kisumu, Kenya, reports on TB research underway as part of the collaboration.

23 Jan 2012

India's Ministry of Health dismisses claims of 'totally drug-resistant' TB

In a January 17 statement, India's Ministry of Health and Family Welfare "dismissed reports that a form of incurable tuberculosis [TB] has arrived in the country," saying "that a team of doctors sent by the ministry found that seven of the patients are responding to treatment" and the cases would be classified and managed as extremely drug-resistant TB (XDR-TB), Nature News Blog reports.

21 Jan 2012

EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC

MSD today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending the use of REMICADE (infliximab) in the treatment of severely active ulcerative colitis (UC) in pediatric patients ages 6 to 17 years, who have had an inadequate response to conventional therapy, including corticosteroids and 6-mercaptopurine or azathioprine, or who are intolerant to or have medical contraindications for such therapies.

21 Jan 2012

Exploring how Peru is addressing drug-resistant TB

Discussing the recent reports of so-called "totally drug-resistant" tuberculosis (TDR-TB) in India, journalist John Donnelly in this GlobalPost "Global Voices" blog entry writes, "Overall, the world is treating drug-resistant TB extraordinarily poorly, and that creates more and more cases of resistant TB that aren't being cured."

21 Jan 2012

Resources dedicated to fighting HIV/AIDS among MSM 'grossly inefficient,' report says

"Funding to prevent and treat HIV/AIDS consistently fails to reach programs designed to control the disease among gay men and other men who have sex with men (MSM), according to a new analysis released Wednesday by amfAR, The Foundation for AIDS Research and the Center for Public Health and Human Rights (CPHHR) at Johns Hopkins University," an amfAR press release states.

21 Jan 2012

Blog interviews UCLA professor about highly drug-resistant TB

The Los Angeles Times' "Booster Shots" blog features an interview with Otto Yang, a professor at the Geffen School of Medicine at UCLA, who speaks about drug-resistant tuberculosis (TB) and the implications of a highly drug-resistant strain found in India.

20 Jan 2012

Shortages of anti-infective drugs can put patients at risk and alter clinical care

Shortages of key drugs used to fight infections represent a public health emergency and can put patients at risk, according to a review published in Clinical Infectious Diseases and available online.

20 Jan 2012

Harare maternity clinics reportedly conducting compulsory HIV/AIDS tests on pregnant women

"In a move that is likely to raise the ire of HIV/AIDS activists, maternity clinics in Harare are conducting compulsory HIV/AIDS tests on pregnant women before they can register for delivery," the Zimbabwean reports, adding, "Scores of pregnant women in the high-density suburb of Glen-Norah told this newspaper that they were being asked to bring their spouses to be tested if they wanted to register to deliver their babies."

19 Jan 2012

TB associated with EGFR mutations in patients with lung adenocarcinoma

Tuberculosis (TB) has been suspected to increase a person's risk of lung cancer because the pulmonary inflammation and fibrosis can induce genetic damage. However, direct evidence of specific genetic changes and the disease have not been extensively reported.

19 Jan 2012

Indian, WHO officials to meet to discuss managing cases of highly drug-resistant TB

Health officials from India and the WHO are scheduled to meet in Mumbai on Tuesday to discuss how to manage the cases of at least 12 patients infected with a highly drug-resistant tuberculosis (TB) strain, Bloomberg reports (Narayan, 1/17).

18 Jan 2012

Tuberculosis News and Research

Latest Tuberculosis News and Research

Watching transformation of the Global Fund on its 10th anniversary

Responding to emergence of drug-resistant tuberculosis

Reflecting on Global Fund's decade of accomplishment, looking forward to challenges ahead

Gates pledges $750 million to Global Fund

Gates urges governments, wealthy donors not to cut aid to poor countries; Annual letter sets foundation's priorities

First Edition: January 26, 2012

Latest attacks in Jonglei, South Sudan, perpetuate a pattern of extreme violence, says Médecins Sans Frontières

Address drug resistant pathogens as part of 'next stage of global health'

U.S. should assume leadership role in saving Global Fund

International HIV/AIDS Alliance releases report examining potential effects of Global Fund shortfall

Cooperation needed to fight TB

India's Ministry of Health dismisses claims of 'totally drug-resistant' TB

EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC

Exploring how Peru is addressing drug-resistant TB

Resources dedicated to fighting HIV/AIDS among MSM 'grossly inefficient,' report says

Blog interviews UCLA professor about highly drug-resistant TB

Shortages of anti-infective drugs can put patients at risk and alter clinical care

Harare maternity clinics reportedly conducting compulsory HIV/AIDS tests on pregnant women

TB associated with EGFR mutations in patients with lung adenocarcinoma

Indian, WHO officials to meet to discuss managing cases of highly drug-resistant TB

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Tuberculosis News and Research

Latest Tuberculosis News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in